-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 POt64grTp+TCT6CqMoDEYoNq+ontnvnv0m57vqsumXfvhGLOcA7XakNxenZBhXBt
 vjgQRINZWNz8pPM4iRrt7A==

<SEC-DOCUMENT>0001193125-06-243559.txt : 20061129
<SEC-HEADER>0001193125-06-243559.hdr.sgml : 20061129
<ACCEPTANCE-DATETIME>20061129134726
ACCESSION NUMBER:		0001193125-06-243559
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20061127
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20061129
DATE AS OF CHANGE:		20061129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN VANGUARD CORP
		CENTRAL INDEX KEY:			0000005981
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		IRS NUMBER:				952588080
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13795
		FILM NUMBER:		061244678

	BUSINESS ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660
		BUSINESS PHONE:		9492601200

	MAIL ADDRESS:	
		STREET 1:		4695 MACARTHUR COURT
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92660

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AEROCON INC
		DATE OF NAME CHANGE:	19720620
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="2">Date of Report (Date of earliest event reported): November&nbsp;27, 2006 </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>AMERICAN VANGUARD CORPORATION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact Name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>001-13795</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>95-2588080</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other jurisdiction of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="1"><B>incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>4695 MacArthur Court</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>Newport Beach, California</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>92660</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Registrant&#146;s telephone number, including area code: (949)&nbsp;260-1200 </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not Applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or
former address, if changed since last report) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;1.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Entry into a Material Definitive Agreement </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">AMVAC
Chemical Corporation (&#147;AMVAC&#148;), one of our subsidiaries, entered into a definitive Sale and Purchase Agreement (the &#147;Agreement&#148;) with BASF Aktiengesellschaft (&#147;BASF&#148;) that, by the terms of the Agreement, became
effective November&nbsp;27, 2006. Pursuant to the terms and conditions of the Agreement, BASF has agreed to sell, and AMVAC has agreed to purchase, assets constituting the global Terbufos insecticide product line of BASF and the Lock &#145;N
Load</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> closed delivery system. The assets to be acquired include the active ingredient
Terbufos, the trademarks Counter</FONT><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> and Lock &#145;N Load</FONT><FONT FACE="Times New Roman"
SIZE="1" COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">, the manufacturing and formulation know-how, registration rights, intellectual property rights and inventories. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Registrant and its affiliates have no material relationship with BASF except as follows: as reported in greater detail on the Company&#146;s Form 8-K
filed as of November&nbsp;4, 2005, AMVAC completed the acquisition of assets constituting the global Phorate product line from BASF for approximately $26.1 million; and, as reported in greater detail on the Company&#146;s Form 8-K filed as of
March&nbsp;24, 2005, AMVAC and BASF are currently parties to a License and Supply Agreement dated as of March&nbsp;18, 2005, as amended (the &#147;LSA&#148;), under which BASF has licensed to AMVAC certain rights to certain patents, patent
applications and proprietary intellectual property related to the herbicide, Topramezone. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On November&nbsp;27, 2006, AMVAC, as borrower,
and its affiliates, as guarantors, entered into a Fifth Amendment to Amended and Restated Credit Agreement (the &#147;Fifth Amendment&#148;) with a syndicate of commercial lenders led by AMVAC&#146;s primary bank as administrative agent and lender.
Under the terms of the Fifth Amendment, the borrowing availability of the term loans was increased by $20 million which amount is to be used solely for the purpose of acquiring the Terbufos product line described in this Item&nbsp;1.01. The terms of
the Fifth Amendment are more fully described in Item&nbsp;2.03 below which section is incorporated by reference herein. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;2.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Completion of Acquisition or Disposition of Assets </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2">On November&nbsp;27, 2006, AMVAC completed the acquisition of assets constituting the global Terbufos insecticide product line from BASF, for approximately $42.1 million in purchase price consideration, subject to a post-closing adjustment
to reflect the value of inventories as of the time of closing. AMVAC financed the acquisition through borrowing approximately $22.1 million under its revolving credit facility and a $20 million term loan, as more fully described in Item&nbsp;2.03
below. The assets purchased by AMVAC are described in the disclosure under Item&nbsp;1.01 above, which is incorporated herein by reference. Other than the Phorate product line acquisition and the LSA, there are no material relationships between
AMVAC or any of its affiliates and BASF, and the purchase price consideration was determined by arm&#146;s length negotiation between the parties. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;2.03</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Creation of a Direct Financial Obligation or under an Off- Balance Sheet Arrangement of a Registrant </B></FONT></TD></TR></TABLE> <P
STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">In order to finance the acquisition of the Terbufos insecticide product line described in Items 1.01 and 2.01 above, on November&nbsp;27, 2006, AMVAC
borrowed approximately $22.1 million under its revolving credit facility and a $20 million term loan pursuant to the Fifth Amendment to Amended and Restated Credit Agreement. The revolving credit facility and term loans are documented in the Fifth
Amendment to Amended and Restated Credit Agreement into which AMVAC entered on November&nbsp;27, 2006 with a syndicate of commercial lenders led by AMVAC&#146;s primary bank as the administrative agent and a lender, two other banks as lenders and a
fourth as a participant, for a $97,000,000 fully-secured credit facility. The credit facility as currently amended consists of a $65,000,000 revolving line of credit and $32,000,000 in term loans (consisting of $12 million in an Initial Term Loan
and $20 million in a Delayed Draw Loan, collectively, the &#147;Term Loans&#148;). These loans bear interest at the prime rate (&#147;Referenced Loans&#148;), or at AMVAC&#146;s option, a fixed rate of interest offered by the Bank (such as adjusted
LIBOR rate plus certain margins, in each case dependent on certain debt ratios (&#147;Fixed Loans&#148;)). </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">The principal payments of the Initial Term Loan are payable in equal quarterly installments of $1,000,000
on or before the last business day of each February, May, August and November, and in one final installment in the amount necessary to repay the remaining outstanding principal balance of the Initial Term Loan in full on the maturity date. The
principal amount of the Delayed Draw Loan is payable in full on January&nbsp;31, 2007. Interest accruing on the Referenced Loans is payable quarterly, in arrears, on the last day of each March, June, September and December, and on the maturity date
of such loan in the amount of interest then accrued but unpaid. Interest accruing on the Fixed Loans is payable on the last day of the interest period, provided that, with an interest period longer than three months, interest is payable on the last
day of each three-month period after the commencement of such interest period. The senior secured revolving line of credit and Initial Term Loan both mature on October&nbsp;7, 2009 (five years from the closing date of the original credit agreement)
and contain certain covenants (with which AMVAC is in compliance) as defined in the credit agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">For a further description of this
credit facility, see the Company&#146;s Form 8-K filed on October&nbsp;14, 2004 and Exhibit 10.8 to the Company&#146;s Form 10-K for the period ended December&nbsp;31, 2004 filed on March&nbsp;16, 2005. </FONT></P> <P
STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Other Events </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">On November&nbsp;28, 2006, we issued
a press release announcing that we entered into the Agreement and completed the acquisition anticipated thereunder. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </FONT></P> <P
STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">(d) Exhibits </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT FACE="Times New Roman" SIZE="2">Exhibit&nbsp;99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press release dated November&nbsp;28, 2006 of American Vanguard Corporation.</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR>
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">AMERICAN VANGUARD CORPORATION</FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2">Date: November 29, 2006</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ Timothy J. Donnelly</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Timothy J. Donnelly</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="2">Vice
President</FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>INDEX TO EXHIBITS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press release dated November 28, 2006 of American Vanguard Corporation.</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px">

<IMG SRC="g41373img001.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B><U>FOR IMMEDIATE RELEASE </U></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>BASF SELLS COUNTER<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT></FONT> INSECTICIDE PRODUCT LINE AND LOCK &#145;N LOAD<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT></FONT> DELIVERY SYSTEM </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>TO AMERICAN VANGUARD </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B><I>Counter Generated Sales of Approximately $25 Million in 2005 </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Newport Beach, CA &#150;
November&nbsp;28, 2006 &#150; American Vanguard Corporation (NYSE: AVD) and BASF Aktiengesellschaft, Ludwigshafen, Germany (NYSE:BF) today announced that BASF sold the global Counter insecticide product line and the Lock &#145;n Load<FONT
FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></FONT> closed delivery system to AMVAC Chemical Corporation, a
subsidiary of American Vanguard. The Counter product line consists of the active ingredient Terbufos, the trademark Counter, the manufacturing and formulation know-how, registration rights, intellectual property rights and inventories. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Counter generated sales of approximately $25 million in 2005. First introduced in 1974, it is a systemic insecticide-nematicide registered in more than 20 countries,
with the main markets in North and Latin America. It is used on agricultural crops, mainly corn, bananas sugar beets and coffee to protect against various insect pests. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2">Lock &#145;n Load is a patented, closed delivery system for granular products that was first marketed in the late eighties. Currently Counter and Phorate, a product AMVAC acquired from BASF in 2005, are marketed in
Lock &#145;n Load. Bayer CropScience LLP has licensed this technology and is marketing their Aldicarb and Ethoprop products in Lock &#145;n Load in the USA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Eric Wintemute, President and CEO of American Vanguard, stated, &#147;This acquisition is our largest to date, and brings a complementary product line and delivery system to American Vanguard. Counter strongly complements the Thimet<FONT
FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></FONT> (Phorate) insecticide business we acquired from BASF in
November of last year. We have been very pleased with Thimet&#146;s performance over the last year and are enthusiastic about the prospects for Counter, which we will begin selling immediately. This acquisition reflects the continued execution of
our growth strategy to acquire and license niche product lines from larger companies in our industry. Additionally, the Lock &#145;n Load closed delivery system offers terrific synergies with our SmartBox</FONT><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP><SUP>&reg;</SUP><SUP></SUP></SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> delivery system, and we are quickly emerging as a leading owner and provider of safe granular delivery technology.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Mike Heinz, President of the BASF Agricultural Products division, stated, &#147;This divestiture reflects our ongoing review of BASF&#146;s Agricultural Products
portfolio. Like Thimet, Counter offers limited synergy for BASF, and is a better strategic fit for AMVAC. This is also the case with the Lock &#145;n Load system, which pairs well with AMVAC&#146;s SmartBox.&#148; </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Glen Johnson, Senior Vice President of AMVAC, added, &#147;Counter brings to the market a product with unique features such as systemic activity, along with the ability
to control nematodes in high value crops such as bananas, sugarbeets and coffee. The addition of Counter to our product line will be a significant contributor to our international business. This product will allow us to strengthen our network with
distributors in specialty crops in Latin America, Africa and Asia Pacific where we have recently experienced significant growth with our other products. We are extremely excited about this acquisition and we see advantages in marketing Counter not
only in Lock &#145;n Load but also in our SmartBox equipment.&#148; </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>About BASF </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">With
sales of &#128;3,298&nbsp;million in 2005, BASF&#146;s Agricultural Products division is a leader in crop protection and a strong partner to the farming industry providing well-established and innovative fungicides, insecticides and herbicides.
Farmers use these products and services to improve yields and quality of agricultural crops. Other uses include public health, structural/urban pest control, turf and ornamental plants. BASF aims to turn knowledge rapidly into market success. The
vision of BASF&#146;s Agricultural Products division is to be the world&#146;s leading innovator, optimizing agricultural production, improving nutrition, and thus enhancing the quality of life for a growing world population. Further information can
be found on the web at www.agro.basf.com. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">BASF is the world&#146;s leading chemical company: The Chemical Company. Its portfolio ranges from chemicals,
plastics, performance products, agricultural products and fine chemicals to crude oil and natural gas. As a reliable partner to virtually all industries, BASF&#146;s intelligent system solutions and high-value products help its customers to be more
successful. BASF develops new technologies and uses them to open up additional market opportunities. It combines economic success with environmental protection and social responsibility, thus contributing to a better future. BASF has over 95,000
employees and posted sales of more than &#128;42.7 billion in 2005. Further information on BASF is available on the Internet at www.basf.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>About
American Vanguard </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for
crop protection and management, turf and ornamentals management, and public and animal health. The Company&#146;s basic strategy is to acquire and license brand name, niche product lines from larger companies that divest mature products to focus on
newly discovered molecules. American Vanguard is included on the Russell 2000<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT></FONT> and Russell<FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></FONT> 3000
Indexes. To learn more about American Vanguard, please reference the Company&#146;s web site at www.american-vanguard.com. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">American Vanguard, from time to
time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by American Vanguard&#146;s management and are subject to various risks and uncertainties
that may cause results to differ from management&#146;s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in American Vanguard&#146;s SEC reports and filings.
All forward-looking statements, if any, in this release represent American Vanguard&#146;s judgment as of the date of this release. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">CONTACT:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">-OR-</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">AVD&#146;S INVESTOR RELATIONS FIRM</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">American Vanguard Corporation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">The Equity Group Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Eric G. Wintemute, President&nbsp;&amp; CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><U>www.theequitygroup.com</U></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">(949) 260-1200</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">Loren G. Mortman</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><U>LMortman@equityny.com</U></FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">BASF Aktiengesellschaft</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2">(212) 836-9604</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Agricultural Products Communications</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Bernd Gerling</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">+49-621-60-28655</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">#### </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g41373img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g41373img001.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`0P$(`P$1``(1`0,1`?_$`+\``0`!`P4!`0``````
M```````!!P@)`@0%!@H#"P$!```&`P$```````````````$"!08'"`,$"0H0
M```&`0,#`00%"08'`0````$"`P0%!@<`$0@A$@D3,4%1%&%Q(C(5\(&1L<%"
M(Q87H<(S)!@*T>%2<D-3)C01``$#`@0#!`<$!0D)`0````$``@,1!"$2!08Q
M00=182(3<8&1L3(4"/"A0B/!T>$S%?%28G*20V,E%H*B4],T1(2TU`G_V@`,
M`P$``A$#$0`_`/?QHB^?J;[_`&1_XA\?JUQB5A!<:AH-,13'[<TQK0@A3W_0
M.H&0CD/[04*^GV*#*=H"/:([?5J5\[6,SN+0!VN`^\J(J30`U]%%K`0,&X#O
M]7U;_MURM<U[0]AJTC`\CZ$QYJ=3(FB)HB:(FB)HB:(FB)HB:(FB)HB:(FB)
MHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB:(H'V?G#]8:@ZE,>'VI]Z+QU>8').3
M:[?K:2LY,R'58\KJ0*BC`7.?A40,FJJJ/IILWK,I4CEV```3]";$V$!#7KA]
M+NS]J:MM:REU/2["YO2P9G201R$X#B7-<#^WO7GIUHW#K=IN*:WLKVZC@\RC
M6LE>T5!-:`$+R>7_`)*<FVDDX29<D>0[0O>L8@-LS9$1*4"JIG+W%):$DE"C
MW"8-AV$`]W36ZT73/IM(XB3;^BN_\*W_`.6H;0W1K+K)DES>3O>[`UD>3P[:
MU]/.N*Z?C7EKR[-E#'S'_5;R24:*Y!J#)9LKG')2J#ALYL<:@JBZ0-:#(JMU
M$U``Q3`)!`1W`0';70U7I=TL;I5Y*-O:&'-MIO\`LK>M1$[@,G'L(X'$%929
MK&HOBSQR3"1S*@^8[C3#GVK]?9N+H$0$H%/]W8!';IV%]_0.@:^<>,M-:<*_
M;T+;!GFB&/+P\IGMRBOWHI(>C_\`I16;E[@+W[`H3<?8(F)OL7;WZ[+8*_NC
MG/8N.2^;;C-<MR-/`]_JJMRW>M7(#Z+A-02_>*!@[R_]Q!V,7\X:XY8Y(?WC
M2*]Q7-#=V]P,T3VGU\/:MU[=<8(/!=A-11-$31$T1-$31$T1-$31$T1-$31$
MT1-$31$T1-$31$T1-$31$T1-$31$T1:3;;;?H_-J!`(Q4'<%XF_,^HJ;(5M*
MKW+)$>/R&('IE-Z*CA0X++BB;N2*B?8""`?0.VXZ]E_I,+?]*V#_`/!!/J`_
M4O-'KB^1NZWAHP,YQ7E>G:K&S*5AM-FFEZWCRJ*^E.61!NF\DI.6?D=*QE-J
M<<!VJ4M:Y9%FL=,BAR-V35%1TY.5(FQ]RK_6'V,D.FV4+I]?N7^"#AEAI5TT
MA`P8W"M,3P:"2NYL.TG?$UY8TX-P]=*X_8J^[F=QSX]<09[QKT+&U"EDLRYU
MQ+A#D)F^:OEVGKC8*I)Y,O,(I2ZU!M(X*Y4HU1.%CG@.BGB5N_U`$.T2E-K7
MKI7U"WMU-;O/7-=OXY-K:9?W>G6#((61PRQV\,HF>7.#YB0<A8[S!SK4%;`Z
MKI%M8VMDV,N^:DM&3/&``KF<,M`,*``@DG'CP7ZAK4-TQ#?;8VP`4?;L4H;C
M].O!V#@?5[@MH&81L;V,;[@5NA*4P``_:`/CL/Z]<^/(T1S&OP>`1WKK<I6(
MY]WK)^HP=CU!RT.*0B("7M]4A3$(H4H@'P'W;Z[MOJ5U:B@_-8/PD`^Q4F]T
M6SNVDC\N0\QACWJC>3<NL..]/G<C9?MU0K.+*RFV=6&^7.?BZI7:TP<O$8YN
MO-V.7<-(R+2</72*)%'9RIF65(F!Q,8-5>"UT;4P7,>;6Y(Q#J9">WM]AY<%
M1S<;ETGPOC9>6H.&6HD`[.-,.\*I%2R=4+F@U5B)5N95XW0=-VZBB8&<-W*!
M7*#AFJ0YT'C=5`X'*=,QBF(8#>P==2_V[K&F'-<1YK?^>T$M/OIZU4K#<FE7
M^5C)`RY=_=N-'*H(#N`?'X?D(ZHV'+@J\*D5(HFX?$-$4Z(NFR.1<?Q%SKN.
M):\T^+R%;V$K*5.AR-FA6-RM$7!$]2<DJY6'3U*;G(^&2'N=K-4%4VQ>J@E#
M1%](/(%$LT_::I7+G5)^TT9Q'L[O6X2Q0\K/4UW+-3/HII:X=@]<2%==2C$H
MK-TWB:)UT@$Y`$H".B+MVB)HB:(FB)HB;Z(N`;VRK.[&_IS6R0#BW1<8TFI.
MJH3$<K9(Z'D%5$&$L_@TW)I1G&/5TC$1742*DH<H@4PB`Z(N?T14S9YIP](9
M`>8F897QJ^RG'(F</\:,[W57.0&+<B1ESN'E-0ECV-JB1`@G$QVQ0`H"/L#1
M%4S1%'3W[:(IT1-$31$^O1%L7<I&L$'SIZ_9-&T6V4>R;ATZ0;H1S-%$[A9X
M_564(FS:I()&.9102D*0HF$=@$=$6UK]BK]MA8VRU6=A[-79EJF^AY^OR;*9
MA99DKOZ3R-E8Y=RQ?-5=OLJ)*'(;W#HBYC1$T1:1]@[_`!Z?5N&VH.%1]N6*
M4K@O&_Y:#QY\M/:C'T5#)>0+;.LH.%B74E-L(Q&2L<D#:&@63&O2D4^D)1X+
MQ$5E5G2:13'`I$Q!,3CZU_33)>/V+'JUSJ7\,VW;0ETA$<;WD,;5Y+I`6M:^
MA8UH!)XDXT7G?U=BB?NJ2R%L;J]N+C*QOF/:T&N!RMXD<2?U+`/;L343D3R$
MP_Q.PHZW:4K,E%QE88N.?2$O7<C2>0L@UVI9<S%3WBZSF3%G$3JX1J:+I5Q_
M\TQ8NDEB[.$B[&6&ZM>VCLG5.I>^*^;?Z5<7MK*^@EMH[:"1]A:RC!H&1I`:
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MTW$<+0Z_7?Y?QD_%?Y8D,3UC*F.4QU#K`"@\TK3%FKCEX^W[%2JE7A[YL\XL
MG<B^,;W(/*2=S)1N5G%'+>5LYTS*_)GBEE"0@LBU^J!:ZW?..>%\,,(_)&!J
M;7+`!J_)UVPIE,CZH&5)\P@H"47L\MI>2"`*IQ5+ZOE7FK=/]M'RR\A/('FA
M<N0ERS'BB!BJ'0,@8\QA)4K$C?&?+M]1%9!*/=UYY!WJRWEH<HR3J3CSB0C=
MLFB'^73,$'-+:5YBJ*XKG)F#(MPYE7_!LKY$U_%UBGC?XT\4<J*#;H>)IR##
M..3[`^<,;%8;/$S48[D[]0:2VC$(U6J5Q(CETY-_!2.H;L-7;7<6H0.;#<3R
MFUCDI04).%>8-1VCO.."M^YVWI;R^[AM877>7G4>PC@>P]M%:_Y,?(KS+I4M
MBO'^,N9V78:7I/COC.8$_+8:##/'.AW.2LC5[_)F:+-:.0+:<O\`9:?:GL:4
MS3%\5"&D=EQ057354V1N;4[#;>MMDN=*<\7,-IYDA:0R(.J,'5(.8C`9016G
M(JC:+-K6F`P:BT_+ON\K`ZKGY",`S**4!H27$8`T"NUC^9G+CG5GSQ#8#J7-
MW)7&%MRR\9EKS)R4G<05+&C>RSF6(.MU6=&9I_\`.=8L435I.6F6[D4U&!1%
M"..NBD1$YP42M/5-OZCHWEF>.L4T(F86$/!80#7PUX5`->?=BKFLM8T_4'S,
M@>0Z"8Q.SC)XP2*#-2M:8+,)X(^3>:N7'C+P9F#D+</ZA98&QYIQ_8[VK$QT
M(_MS;%>9[WCR`GIJ.B$D(Q.=>U^NM1>'133*NX`R@AW',(T;`XM-1[/>JG0@
MT<*'V^Y4$\Z4,PP6/`SRBMVZZ#GQY<M:9)Y7EHV-4?2B?%7D0[C\-9\1(#4I
MGBQ6329C7::?:H0!34^R`F[M1`J:(L35'R1EG#/CWJ_*>I93RWB'DOYOO)K+
M98CU\0TG$\MG.W87O$E;OZ/8?HUWSQ8ZSAK"/JX;J;&3;66=%\WAV\BJDDT4
M46$R<7-RFB+84?R1^0N?\<52<QO*.5K^<(KSTU/QW1^;)V)P=ERV%P;//FK-
M"-R#(4RO)X?RI-0[B?#YB7A$&S:6(S(**X)F%0T7LR4YU154O/D`Y_\`#GC9
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M*>,>,V+Z+,Q>'(R?G<=V?C?C+%]CN&?<7U&%6BBQBZV0)`%YX2JG31$Y%!2(
MNJ8S\@/E%AO#-G#R5WGF9%V^XY&RE$\:L1QLO@_','4>*\,CR[E\-VGD%<'\
M/'-6M]LB,+)F333>,4HQ@V:L3*D74!P*A%>IXPZ]=*MYR^=-:R!RZC>;5BK7
M`+BY%%S>E6\=UFP+Q[B[3,DA6[DRQ<"51<V*-%Q\P#E%)-9:-=LQ7`ZH&54(
MO1=R0E;[!\>,]3>*V[AWE"'PQE&5QNU:)"L[<WV/H\X[I[=JB!3BJX6L2+8I
M"[#W&$`V'1%XV>%>(O"&GXP>`'(W.%V;U3F3;<OXYF9#/>%+.\E.?ECYKSV1
M9(+!3I!Y$,K;E*60<V=99L^C7[%2/)$BFX$$_43<&(KJ.='.[F6_S]Y:)C'_
M`#TJW"6`\4N/,:V[#7'J4QYB>Q&Y8RMDQ,IDZ0F<ER&1VBMJDZM=9QN2K0[:
MN"F""[M(_=\V!?6(JX)\JN?_`"^\C?!?!&+^09.(.*\K^+?!7D#Y!XW#$E.O
M\^XL#C,D*E<L85F8LZ2,]5G5LCI=O!NWAW:P,8HBQTF_SIRJ`16#\C?(QY"J
M1"^5SE'5_(55JLS\='D6>X7Q'PCE<383>CFS&LI=L:UYI2[385H5+)[YA+1=
MF>MZ\K';/P=1K]15RJ(%.SAE!.)</0BNKYI\XN9MUY4>1>HT'G-6O'=3O'%Q
M*P[G_'&/9[&V(;7)<H+ED/$<QE><5NLCE=J_D'5!KTS%)U$S:O%27*^=E.("
MX],BD47(MN:'D6YH<HO%'B?$G(!CPQ@N77C;8\P^0T*WP[3\DO$YZ%MU1DIE
ME1"75$)FO+6UFN$8V57>F28P\@LKZ*KTJ1R$5M'-WRD\WL>\Q\OW;`/(G)4Y
M@W!'D%X]\.)G'S;#_&BL\8(DUJD*M%9/Q?:9V_V*2Y49;R\J:477-*5F/8Q$
M20!.10J!._1%7FLPV0JUYCO]P#,R.>;!9(BO<"\7VAGBRS5O'+VK6!E9\(7*
M7JL(^C%H`7CV`Q`BR49M@2`!E$)4X2YW9O2$2*FV%^7G)J<XP^`WA_BG/].X
M(0'-#C1E&[Y(Y-5K$>(2I1;W#=09ST!AW$=-M$,RP[4):X.WYE7`%8$5(U(7
MY,G>*A#D6AQY0O(3;N#N&D:1R#I:.=D/.9$>+T.7,5B.CS5'Y!X=-*6.#;9C
M0QRY;N*F0))=RT%T$*HS16<1ABMUTBJJ#HBRO^)7//*.QY[\F?$#DWGAQR;=
M<)<[8HJN/\V3M`I..;K9:SES%XY`<Q%H@L=1L/4U!K<@F*+59%L18R9S`<PE
M!,B9%FY4'8@B/T==OI#W!J!('&M"0,._#^7N4'&C'$<FGW%>47R2I?@5@ON8
M:PY.?,B\98*-B6KOGD9&.QL3EDY@)_+=:/*+M6KA>I5=VJV8)F4!P-@<$6;`
MK\L<J?IOT*<ZZT:QV3J-?]'!\5U?SL:Y[0QI#[:P?E#BUTMPT/E(!!M0YKBT
MN%="^H)CM-3EW,R4.UASGP6\1P=62H?<LS4%8FX5)QK@#1>8_@MRHQ-P'Y95
M#DGD7'M_R-/8U)<HMGCV$6JD7%'>2\&Z@XV2<S<V^,]0DH"25,X[`:B45$""
M!RB&^MUNM/3K<G6+IY?;&T._L+#2=2D@>9WMG=(!')G<QHBI1LC/`:^$M)%`
M<53.F.M1:+>0:G<1MD,3G/`-?C+2UKL`?A)S4IW`JP>O3T3D3FA1+Y$R-KD5
M\A<D*=<YE]:F41&RPV*WY493<P7Y>)E9B/,U3>OC`FKZH*&`1W*7H(WCJ&FS
M:)TJU#3+D,!L]$N(H_*S!@AAM',;4/\`%3*W@:D=I64(KAT\T<CR'9G"O'&I
M&/;4G'T\N2_72G\(X:M,O;[%9\2XTL5@O]*#&M\FYVBUF6F+KCH%5EPH5MDG
MT:N\L=,!9TH?\+>'69=RAA]/<P[_`#@L+@PL/PYB?O/Z%MP#2A'Q`46Z@\.X
MDJUAB;?6L78\KUL@Z)'XKA;/"TRN1EBA\81+DCR+QS%S;*.1DF%$C7:)%6\0
MDJ2/14(4Q4@,`#J9Y+ZY\:\472\8\5>,&%K/=+MAWCM@_%=QR.=4^0+5CK%5
M'I=BNHKKF=KA:9FNP<=(3A%W1A5.5RHH4ZHB<P"81'1Q+QE=B$7.$X]8$2Q*
MXP(EA'$J>#7*+ALXPT3'=1+BMPV=S!K"Z05Q^6("J'0<SYS/CD%IVF>"*P@*
M@]VE2>*+@,L<3^+N=W-(>YNXZ8/R\[QFNBYQXZR7BRDWAQ2%6XIBC_*JUDA)
M)2#23%`@@FV%-/=,H]NY2[31R/B<71DAQKCZ5`@&E>2V&7^'W%'D%-5JRYQX
MVX-R_8Z9%2$'49_(^+J;<)NL0TJ0Z;^*@):=AWK^(8."J&_A(*$(43")0`1$
M=3PW$]N\20.RO'LX4-1P-1AB"N.:&*>(PS`F(D&E2#4&H((((QIP*LNR-XXL
M:T]U4K7@_&=':N,9UI[4,?QC&KP4=9\=TJ1.)I*H8XFT$&BT56'290(>/04;
M@)0#_%-K.NS>J.E^?%;;GMXF21Q^4VX:P90P@#*YH!IP%:"APP`6&MT].]3$
M,TVA7$LT$LOFN@>XDF0$D.!)%2*X5-:U5(,!Y?>\0:^RP_4,=56!QI7)*250
MQW$5UK1PKSJ;EGDW/.(]&+CVC=!S*2S]9RN*J"H*K*F4,83F$1R-KW2+:F\H
M?XIHTORMX\5:Z"CH'889@"13MH059&C=1MR;:D%GJ0^8M6_$V0D2M[ZFE>RE
M3Z%D$@LQ\:^6-,GL772.J]EA;I$N(*WX@RM#Q,@PL<4Z!--Y$OX*9(\@;/&N
M#F`/3*"O?MN*91#6OFZ^F6\=FO=-J,'G:4,&W$(+V$\:&GB;A_.:,0<2LT[;
MZ@[9W*[R;6;RK\LS&*3!U.XGPD>@U[EWW)O%GC-FG%,)@K+>!,0Y(PS625T*
MUBRYX]K-@H=<)4FI6-7"OU>2C%XB$"`8$^7:?+))>@W$4B[)F,4;`:\2-SC$
M'U'V'%7P<*5X$T7$Q7#3B1!P"%4A>,>!86KM<GP&;&M9A\3T>,KS3,-4:M6-
M9R@TA&,(A&-K[`,F**3.532*];II$*10H%``F+G.^(U1=;SMQ`I.4,8\DZIB
M]^PXX9-Y/0\:TR+G;&N/\?25XL$O`1[>&@).\L+97I:!R6Q:UY`T0NRF47!5
MH=PLU340[RJ$@BL2\=WAZ@N%6;,F\C+_`)/Q[E?*%_PI`\=8V#Q#Q@QCQ/PK
M4L315G<7689HXDQR^FXF=M]WMJP/I>6=..Y<P"D5(J8@4"*^3#_CYX,<?;.P
MN^#>(G'3$MSBG-L=1MMH&(J35[*Q5O3-"/MQ6L[%0[:32;3\>V3;N$05!$S<
M@)@4"!VZ(MAB_P`<O`K"EYC,FXCX=\<L;9%A+).VZ$O=+Q+3:_;8:PV>/=Q4
M_(1%@CHI&4C/Q2-?KH*HH*IH"DLH4"`!S;D5687B[QOKN%YKCE!8*Q1%8"LB
M-E;S^&F=%KJ.-)E"Y23R9M:<E32L/P%X6PR[]9T[[T!]9RJ94VYQ[M$75>/_
M``DX@<4GKV3XT\9\)8*E)2NLZE+2N+<<UBF2LQ7(^3=S3.(F).$CFC^7:-Y9
M\JX*#E14?5.)M]]MB*Z+1%9K6_'?P2IV>'7)^J\1./->Y!O)1].K9>B,55%C
M>`GY0JA).PMIE",(LSL,D58_S#]$"/%A4.)U#"<VY%RV:N!G"SD?D:H9=SYQ
M8P/F')M"*R2J=YR+C*JVNR1+>->#(QK,)*7CG*SUA&OS"NV;N?6006,8Z9"F
M,(B15E_HQB0F64,]!CFF%S0TH!\5-\I!7XX+RWQHI.$LJE$1L@(?B:55/8$R
MO!9`IZ'S(`?M[@WU*YS6-S/(#1S.`1842>.'QY\*LE<E^9?,J*POG+(F;^:U
MTY,X/G+KA.+F\K46SW]E6$*[A#$T8FYM5IRI9F<_7OFXQ%BU(H+QQZY&B)R'
M7&X=K;4W%O;4SI.V+=T]Q'&9)G'P16\(XS3RORQPQCB7RN:T#MJ`:3K>MZ7M
M^T;=ZM((XW/#6-&,DKSPCC8/$]QY-`-5?`]X?8"YSKU?-G-_@K@N6N5==>IA
MZ+R]3JKD3+%.HP*IOXMED>559NX=E-/Y$ZCY2NMUI&/BC*`F=99SZI@DW)IV
MCZ/J+--T:^.HMC81-.UF6!\H.(MZT>Z-E2T2O:TSTSY&@"LNC76J7MN;O481
M;QR4,<1_>L;V34);F.!HTX#`XU5Y"N#<.KY/JN:EL94D^6Z-29+&U-R-_+L:
M6W5C'\P[;OI2EP4T1`KR,K+YXT2449I&*@8Z91[>@:H:K"MQO7C.\?63LF6[
M,N0^&W'2YY5OC^#EK=?['BRK2MIFYFMN(YU"SCJ5=,3N"3S%>);&!\F)'9_0
M(!U#`&VB*KDUQ*XQV++\]G^<P/BZ4S;:L;R.'[-E-W3X=6\6'%\NV*RDJ)-V
M$6P2$I6WC(A43MESG(*)0)]T`#1%U._\#N&&4\&4[C/D7C!A.XX"QTG'I8^Q
M/.T"`>TRBEBDE6\>>G11V@$K*S5LX42*HR%!04E#D$PE,8!(NR-^'O%=ICO$
MV(V?'K$#'%^![E6\B89H#"AUYC4<9WZH.'KRLW2FP35BE'P=HAGLDX71?(D*
MY!==103B<YC"1=\I&$,0XVNN4\D4''%0J%]S?,PEAR];H"%:1T]D><K42,%7
MY2WR*"97$T]AX<PMFYUA,*2(B4NP#HBJ>IOV[@82["`C[-C!\!W`>GU;#J(X
MJ#OA/H/N7A^\T$D[D\B615^[5>ID4>-TD>U,"MD6JCHS!LR;F*FFB1+N^R4@
M@`?>`.[<P^SWTE6UM:;/MX8,L;:,E=@*R/`XN+JDUYTIPPHO,CK/=SW6YRZ=
MV8F;*.08`3@VF`&)K6J\EV2'8FDW!A2!%,%'(B558BX@(&V`QA.(>FH?W!TW
M$0Z]-;Q6IC>2WPM:.0/ZU<&S88Q8QO#FO<ZF`!P_9Z5L>-KD%>4''=,H$$39
MSQ"50$R)B(D_J!7B%,)BB8I#J`(")1#[6_N`=6UO\C_0FO!IK_DE]_ZTJS!:
M0@")U"!F;Z.(7[,.X!N`_'X;_#7S0MX>L^];;CB?MR6O;?VZF45`AT';H/Z/
MU:(M(?='<1Z#MO\`HT12/=U^[M].^B*"@.PCT#?;8/=HB@P[!]H"B/U=-OSZ
M$5%#P14<RE@;'.66IOYEADTI@B7IL[)&D0:SC38H@0/FQ14*Z0)_ZEBJ$^``
M.PA=6U]\;BV6X?P69WRE1F@<2Z-PKB*$U!IS!!5J;BV9H&Y8B+^%HN:&DK11
MP-#C7@>/`K#WG;B!E'%8NIV,:N+K5&@*.FT_5&:J<M$^DX!5%:7B6A1?,SIE
M`!.N@9=(!#<!+MMK<S8G6S:.[,NFWI98:HZF:&:CHY*C'(YV&)X!U"1@M9MX
M=+=?VY2ZTYGSMB*_G-)#HFCAF#2"<<,/UKH6*N=&;L0IH,7DD7(M69"V:#`W
M(SQ659MR&5[D6-B()Y)NH8NQ2>L5RDGN7[&P;:J^ZN@VQ-WL^<LV'2]1D)<R
M2(CRWN/-T1J,O/PEI..*IV@=7]W[<+H[HF^LXO"Z)X\36CFP@@U_K562W#WD
M9X]Y.5:Q4_-&Q99URE3-%78Z32'4>B([MH^U%$D4X^QU#Y@&AQ_Z=PUK+O'Z
M=>I&T\]S:PC5=(%7-EMF.\S(*>)]N2Z1HY%P+A7TU6?MM]9=F:_EM[B86.H.
MX,G<U@/*C7&@)[NQ7XLGK60:-WS)RW>,W:1%VSMHNDX:N45`[DUF[A$ZB2R2
MA1W*8IA`0]@ZP=(R2%YBN&NCF!H6O&5P(Y%IQ![EE2.2.:,2Q.:Z-PJ"TAP(
M[01@0MUJ7@ITT1-$31$T1-$31%`C[.H:@7`4KSX)SIS6*OE/Y-*]1,E_Z3.(
MU,+RXYNS*1TT,35*3]"@XB;F,1(]TY%Y*:@XA\=U>&.H"BS+U#2[O[**:21E
M"*:SML3H=?ZUH!Z@=1+N/;?2V+$WEP!YUX0?^GTVW<"ZYGDIE8:>6#5Q<<I"
MLS6=XPV-S_"M&C-[KKW96QL%6L.6I,AJ!X002*B@(S%M05WKBSP=F:=;TN2G
M+?(I.2W,>18+M27]U'_(8UPE#2>ZCO'W&VAN/49T*M)E,"3J5,49V:[14=+@
M4XHA3-^=6;36-+=T_P"FUB[;_2^"0'Y429[N]D:`!<:G<?'.]P%60$^1$T@,
M949C+HNTW079UO7Y3>:ZZM'.H8H037);M(_+IS?\?($--%D:``*``'L`-OT=
M-8=5ZJ=$31$T1-$31$T108.X!`??J!:UPH[$5!]AJ/O3`X'@K0LJ\"^(V;'K
MJ0RA@FD7%X]$QG+B43E2*JG.8QCG[F4FU[#'$W42[".LJ[<ZX=6]HV[;7;6O
MWUG;,X,9Y):.'_$B>>0PK3NXUQ_K'2OI[K\QGU;2H)ICQ=FD8:\:T8X"O?Q5
MJLOX-?%1-#WR7#7'2YA-W=R<]D5H(F'?[7^4N2`;]?;J]F_5O]2#*TW5?FO:
MRU_^9<=MTJV):,\NULG1M'9/-7T8OX+B*_X&O$Y5[3`W:O</:G#V6L3\39X.
M28WC+)#,)V#D$)2+D4VI[ZHS5.T?MB'`BB9TS=O:8HEW#73O?JH^H74K2;3]
M0W+/)87$;XY&^1;-<YCVEKFF1L378@D$BA()"[[>GVV&.:]K)ZLI0&:1PPY4
M+J$=Q67HH#N8!W[1$1Z_'IK7]C&L:&M[_6222?:5>Q-?8OKJ9031%'0-_=UW
M'1$'V#]0_JT1:2B.P[@.P;;=/U?'1%/<&X`/3<-^O[=$4[[^X0^D0T10._:/
MO'_GJ5S<PR\$]/!6>YMX38=S(+R6)&A2+BY`JO\`,U:011(Y=%'<JTU!"4L9
M+G$!$!4$$U^O10-9?V1UKWMLMK;,RC4-%&!MYR<&]C)161@'$-!RU_#BL:[K
MZ5[6W1$Y_E_+:E7,)8\#F[7#GW]RPQYUX%YTQ4G+3:%>)D:K)F644G:0F,@_
M3;N2F2(#VNJ('FF?I=_\4R23A(.@^IT$=;I;!^H?86Z76]E=7$FFW^4#)<C*
MVN'"4>`UY!Q:>Y:O;TZ0;ST$FZ;`V\L6\9(C6@IQ+#XO8%9Q0\^YQP3*$D,:
M9*L-8!FL+5>NB^6E*_W)"0#-9.IS3=S$[E(.YQ]`#D`!V,`ZS)N#IIL#J%$Y
MVY--M[M\P!;,QC6R"O![;B,YJX8'GP."QQI&^-U;/>9-$NI("#^[DD-,.7R[
MQ0_U?6K[\=>:2_UA)%KFG&=8N#8GH$<3M$E%:O+@`[%5=+Q4D$I#K")1`P$(
MHT+U]WLUK_N3Z(M$O"Z;9.KW%I(XU,=VWSHP>QKV@/`Y?"['%9<T/ZH-4MG"
M+=-@R[BI\<!\I_\`9)RGMXCL5_..O+[PDO*C-E-WZ5Q;+.B$'Y+(]?>QC--5
M00]-,9^(_&H``5`P"4QW)`V$-^T>FL`;E^DOK?MUKYH=+&HVK/QV<C933C7R
M_#(!VG+2N&-5F;1?J%Z9ZJYL5Y=OTZY(^&Z88QZ`_%I/=6M,>`5[-4Y"8-R"
M1/\`D+,V++2JJJ1$J4'>JO*N/5$2G%`S)K+?-E6,EOL42@(;[[#MMK!^J[,W
MGH1<W6](U*U<T5=YEO(QK1VEQ;0!91T[=6VM7#7:3?V=R'<!',QQ/H:#4JKZ
M2Z2J9%$E$UDSE`Q%$CE43.`_O%.01*8!^@=6O)((G9)/"_L.!]RKX\0JW$>I
M:C*``"(]``!$3#L```!N(B(]``-2MF8XTKB>RI]P0X8NP'J_6J.Y"Y$8)Q&R
M=264LRXLQZP9$,HY<W+(%5K@)E(43"`)2DHV64.(!T*0IC#[@U<NC[1W?N*5
ML.WM)U&_D>Z@$%M-(23V96$'U%4>^W!HFF$_Q&[M8<O)TK0[^S6OJ6(+D1_N
M+/'+A5M)-:-<;5R*M+-(Y6T1B:N/"U]5X504BI.[S;$X"`(U$Y>JK,7X[=2D
M-K9S8OT.==MYS-FU>RM="TES:^;>RD2AO\[R(6R2@=S@W&JQUK76O9FEC)9O
MEO9BX"D;<K,>V23*WACA7#%6C4VZ>7WS"F25C/6\;?!Z?[?Q&P13>3-G+)-9
M5/LNRK4W)-XBQO$I-HL)!>,T8&(,GO\`Q'H;IFR5J>B?2U]+I`E>WJ'UEB-?
M)D=_E5O(!@7>63%(QAH3$XOD+J$M:`2K7T[4>HO4]KV0L.C;6=X3(*^8\9B"
M&.-)"2,:^%G:3@#GCX>\(>.W!W'/].^/]&;5Y*16)(7"XR:GXQD'(DZ4!]2?
MO-L<D"0F7JBASF(B`ILVOJ&*W12*(AK3SJ5U3WOU9U\[@WK=F>8#+#"T!EO;
M1CX8K>)O@C8T4`H*FE7$G%9BVWM72-JV/R6F,\6&:0XOD(&)>?3R%`!P"NX`
M?=L/U[=-8]5QK5HB:(FB)HB:(FB)HB:(H$-_>(?5HB@P;A_;HBGJ`!TW'8.F
MB*![M^@;AM\0#KHBU:(FB)HB:(H]W3IHB=!^`B'01V]X:(IT1/CT^H?CHB:(
MM`$+\.OQ#H/7X;>S4A8TUKS]*B"1BK=,Q<4,"9R;+IW[&T$]DES@H-DBD"P-
MH*L4!`JIIZ*!L_<]H"/V%S*IC[RCK(&S^J74#8EPV?;&HRPL::>5(3+"0.V)
MQ+2.[!63NCI[L_>``UVSC?,":2-:&R`GGF`K[UBTRYX4:[,E7=XBS#*P2Y!'
MY2&O\(QL#4$![C"T_'X@L8^32,8PANHT<#VCUWUM1M+ZW-=MA\MO31;>YA!Q
MEM97P2._I9#F:#W`@+`NXOI;TFZ:Y^VM2GMI3CEF8V5H[@<"!W4[UC"RIXB.
M9U5;KGBL>1.06;1%4ZSRBW"NJN'H)B=1,6<+/K0,F=P!A`Q"%3$>XO:`]0'6
MS&V/J]Z*:A(TW-Y=:;*_#+=0R4:*#^\@\QIQ!P."P5K/T\=4[!N06-O?CF^&
M9KB1_4F+"/4*]BQ_73@ERW@".`E.,N:VCE!8RA%F=!F'Z9#E,0_:5Y#(/RJ)
MF3$QA.10WVC"(>S6<M+Z[=&M5:T6NZ-">QWX)+F)KO0Z.<M</0YHPQ[%C/4.
MF?4+2*MDT?48B/AR1O/L,=?N*I8G@'G"S<*-ZQC+EC'F$QD2,8.!RTP1`Z8>
MGW)%:HLB)"!E#;[@4NPB(#U'53=OOH6]KGZAJ>TG%QK5[[!U1Z2#]L5U8MO]
M2HZ,BM-<'H;<KMC#QQ^6'+RH,T,6\E7+=YVB1:^WJ4JT$=-7MW*X&[6V/!-(
M@`;N,!#"(#[!W#5OW_7SZ4]LETL^J[==<,;5K;.TBN7DCE^1`YK?22!6@KBK
M_P!%V%UKUEC?(T_51;G\4K_+`[_SI&D^@8CL5W.(/]L3R8R&_9R7(/,6/,0P
MJQB*2<=5_P`0RC>Q*8-U$A<?_/5DCG]WU!>.2@'N-MK"&\?_`-!NGVC1R6_3
MW2-1U"=S2*S2?(VU>66.$EQ;VM+&569-L?3WO:YE;/N6XMK1F!<0YUQ*[_8/
M@81A2DA'N7H(X;^$C@?PV<1ME@\:*9>RBP33$N3\TG8W*6:O2@4QWE>K1F;6
MF594JH;I*M6/SB7L^8,(;ZT5ZI?59UGZIPR6=UJ4FE:%+@ZTL<T#',K\$CVR
M&24GM<\@CDMBML]*MI[;<R;R/FKUN`DEH\`T^,1D96GE3Q'O67HJ9"AT*`>S
M\P`&P`'P``]WLUKMW\UDX&C0T8-`I08!:@``#8`V#\AU```4'!2@`"@X*=14
M4T1-$31$T1-$31$T1-$31$T1-$4![_;[1]O[/HT13HB:(FB)HB:(H_>#[W]W
MW^WZ=$3]X?O?W?=[/IT13HB@/?[?:/M_9]&B*=$31$T1:%/N_E\-<$^;*,M.
M/.E/O_1BHMXK9)_XAOK_`/'O\`^_MTVUUC7&F:M>5/+]=</VKE/PBN>O]+]%
M,%N>GT_VZE_,_P`/_<4%MFW^(?[GW1^OW>W\O9KG@R9_#YW#\>:GJS*:7X1\
@=>_AZN2Y#7;7`FB)HB:(FB)HB:(FB)HB:(FB)HB__]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
